Related Experiment Video
Updated: Jul 19, 2026

07:48
An Orthotopic Bladder Cancer Model for Gene Delivery Studies
Published on: December 1, 2013
[Bladder cancer with skin metastasis: a case report]
Naoki Segawa1, Yatsugu Kotake, Syuji Hamada
1The Departments of Urology, Osaka Medical College.
Hinyokika Kiyo. Acta Urologica Japonica
|October 17, 2006
Summary
Skin metastasis from bladder cancer is rare. This case report details a patient with transitional cell carcinoma (TCC) of the bladder who developed skin metastases 13 years after initial diagnosis and treatment.
Area of Science:
- Urology
- Oncology
- Dermatology
Background:
- Bladder carcinoma, specifically transitional cell carcinoma (TCC), is a significant oncological diagnosis.
- Metastasis of bladder cancer to distant sites, such as the skin, is exceptionally uncommon.
Observation:
- A 68-year-old male presented with macroscopic hematuria, leading to the diagnosis of TCC of the bladder.
- The patient underwent multiple treatments including transurethral resection of bladder tumor (TURBT), intravesical chemotherapy, intra-arterial chemotherapy, and eventually a total cystoprostatectomy with neobladder formation.
- Over 13 years post-diagnosis, the patient developed multiple cutaneous nodules consistent with TCC metastasis.
Findings:
- Histopathological examination confirmed transitional cell carcinoma (TCC) with muscle invasion (pT1, G3) initially.
- Delayed diagnosis of skin metastasis occurred 13 years after the primary bladder cancer diagnosis.
- The patient's advanced age, renal dysfunction, and widespread metastases contributed to a poor prognosis, with death occurring four months after skin metastasis manifestation.
Implications:
- This case highlights the rare but possible phenomenon of late-onset skin metastasis from bladder TCC.
- It underscores the importance of considering unusual metastatic patterns in patients with a history of bladder cancer, even years after initial treatment.
- Further research into the mechanisms and risk factors for such rare metastatic presentations is warranted.

